Drugs / MWAV201
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06663878 | Oct 2024 → Mar 2026 overdue | Wilson disease | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MWAV201 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06663878 ↗ |
| Route | Intravenous | “single, peripheral intravenous (IV) infusion of MWAV201” NCT06663878 ↗ |